» Articles » PMID: 2179292

Therapy for Cutaneous Melanoma: an Update

Overview
Specialty Dermatology
Date 1990 Feb 1
PMID 2179292
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This article reviews the current therapy for cutaneous melanoma. Diagnosis, staging, and prognostic evaluation, which are crucial to proper management, are discussed. Surgical excision is the treatment of choice for primary melanoma. The resection margins should be tailored to tumor thickness. Guidelines for surgery are presented. The controversy about elective regional lymph node dissections is discussed. Limb perfusion, chemotherapy, immunotherapy, radiotherapy, and hormonal therapy as adjuvant treatments of primary melanomas as well as the treatment of disseminated melanomas are reviewed and new developments are highlighted. Guidelines for the management of metastatic melanoma at various sites are given. Special issues such as "pregnancy/estrogen and melanoma" and "borderline melanoma" are discussed and approaches to these problems are suggested. Recommendations are given for the follow-up and counseling of patients with melanoma.

Citing Articles

Long Noncoding RNA LINC02249 Is a Prognostic Biomarker and Correlates with Immunosuppressive Microenvironment in Skin Cutaneous Melanoma.

Du M, Han L, Shen P, Wu D, Tu S J Oncol. 2022; 2022:2054901.

PMID: 36117849 PMC: 9473915. DOI: 10.1155/2022/2054901.


Common Skin Cancers: How to diagnose and treat them.

Ho V Can Fam Physician. 2011; 38:845-54.

PMID: 21221380 PMC: 2146082.


Malignant melanoma in a black child: predisposing precursors and management.

Adedoyin O, Johnson A, Ojuawo A, Afolayan E, Adeniji K J Natl Med Assoc. 2004; 96(10):1368-73.

PMID: 15540891 PMC: 2568537.


Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Moller P, Sun Y, Dorbic T, Alijagic S, Makki A, Jurgovsky K Br J Cancer. 1998; 77(11):1907-16.

PMID: 9667667 PMC: 2150323. DOI: 10.1038/bjc.1998.317.


Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo.

Schadendorf D, Kern M, Artuc M, Pahl H, Rosenbach T, Fichtner I J Cell Biol. 1996; 135(6 Pt 2):1889-98.

PMID: 8991099 PMC: 2133968. DOI: 10.1083/jcb.135.6.1889.